APO Research
Talk to an analyst

APO RESEARCH · REPORT

C-C Chemokine Receptor Type 5

Compare research editions
View pricing & licenses

Selected research

Industry Research

C-C Chemokine Receptor Type 5 Industry Research Report 2026

26 December 2025117 pages

Choose your research edition.

Industry ResearchC-C Chemokine Receptor Type 5 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal C-C Chemokine Receptor Type 5 Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal C-C Chemokine Receptor Type 5 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C-C Chemokine Receptor Type 5 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal C-C Chemokine Receptor Type 5 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global C-C Chemokine Receptor Type 5 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for C-C Chemokine Receptor Type 5 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for C-C Chemokine Receptor Type 5 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of C-C Chemokine Receptor Type 5 include Allergan Plc, American Gene Technologies International Inc, Bristol-Myers Squibb Company, ChemoCentryx Inc, Cytodyn Inc, Pharis Biotec GmbH, GlaxoSmithKline Plc and TaiwanJ Pharmaceuticals Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global C-C Chemokine Receptor Type 5 market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

C-C Chemokine Receptor Type 5 Market by Company

Allergan Plc

American Gene Technologies International Inc

Bristol-Myers Squibb Company

ChemoCentryx Inc

Cytodyn Inc

Pharis Biotec GmbH

GlaxoSmithKline Plc

TaiwanJ Pharmaceuticals Co Ltd

C-C Chemokine Receptor Type 5 Segment by Type

DS-001

CCL-14

BMS-813160

AG-1105

Others

C-C Chemokine Receptor Type 5 Segment by Application

Infectious Disease

Immunology

Gastrointestinal

Oncology

Others

C-C Chemokine Receptor Type 5 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-C Chemokine Receptor Type 5 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-C Chemokine Receptor Type 5 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-C Chemokine Receptor Type 5.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of C-C Chemokine Receptor Type 5 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of C-C Chemokine Receptor Type 5 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of C-C Chemokine Receptor Type 5 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global C-C Chemokine Receptor Type 5 Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global C-C Chemokine Receptor Type 5 Sales (W Units) of Manufacturers (2021-2026) Table 7. Global C-C Chemokine Receptor Type 5 Sales Market Share by Manufacturers (2021-2026) Table 8. Global C-C Chemokine Receptor Type 5 Revenue of Manufacturers (2021-2026) Table 9. Global C-C Chemokine Receptor Type 5 Revenue Share by Manufacturers (2021-2026) Table 10. Global Market C-C Chemokine Receptor Type 5 Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global C-C Chemokine Receptor Type 5 Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of C-C Chemokine Receptor Type 5, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of C-C Chemokine Receptor Type 5, Product Type & Application Table 14. Global C-C Chemokine Receptor Type 5 Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global C-C Chemokine Receptor Type 5 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Allergan Plc Company Information Table 19. Allergan Plc Business Overview Table 20. Allergan Plc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Allergan Plc C-C Chemokine Receptor Type 5 Product Portfolio Table 22. Allergan Plc Recent Developments Table 23. American Gene Technologies International Inc Company Information Table 24. American Gene Technologies International Inc Business Overview Table 25. American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Product Portfolio Table 27. American Gene Technologies International Inc Recent Developments Table 28. Bristol-Myers Squibb Company Company Information Table 29. Bristol-Myers Squibb Company Business Overview Table 30. Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Product Portfolio Table 32. Bristol-Myers Squibb Company Recent Developments Table 33. ChemoCentryx Inc Company Information Table 34. ChemoCentryx Inc Business Overview Table 35. ChemoCentryx Inc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. ChemoCentryx Inc C-C Chemokine Receptor Type 5 Product Portfolio Table 37. ChemoCentryx Inc Recent Developments Table 38. Cytodyn Inc Company Information Table 39. Cytodyn Inc Business Overview Table 40. Cytodyn Inc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Cytodyn Inc C-C Chemokine Receptor Type 5 Product Portfolio Table 42. Cytodyn Inc Recent Developments Table 43. Pharis Biotec GmbH Company Information Table 44. Pharis Biotec GmbH Business Overview Table 45. Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Product Portfolio Table 47. Pharis Biotec GmbH Recent Developments Table 48. GlaxoSmithKline Plc Company Information Table 49. GlaxoSmithKline Plc Business Overview Table 50. GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Product Portfolio Table 52. GlaxoSmithKline Plc Recent Developments Table 53. TaiwanJ Pharmaceuticals Co Ltd Company Information Table 54. TaiwanJ Pharmaceuticals Co Ltd Business Overview Table 55. TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Product Portfolio Table 57. TaiwanJ Pharmaceuticals Co Ltd Recent Developments Table 58. Global C-C Chemokine Receptor Type 5 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 59. Global C-C Chemokine Receptor Type 5 Sales by Region (2021-2026) & (W Units) Table 60. Global C-C Chemokine Receptor Type 5 Sales Market Share by Region (2021-2026) Table 61. Global C-C Chemokine Receptor Type 5 Sales by Region (2027-2032) & (W Units) Table 62. Global C-C Chemokine Receptor Type 5 Sales Market Share by Region (2027-2032) Table 63. Global C-C Chemokine Receptor Type 5 Revenue by Region (2021-2026) & (US$ Million) Table 64. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Region (2021-2026) Table 65. Global C-C Chemokine Receptor Type 5 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Region (2027-2032) Table 67. North America C-C Chemokine Receptor Type 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. North America C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 69. North America C-C Chemokine Receptor Type 5 Sales by Country (2027-2032) & (W Units) Table 70. North America C-C Chemokine Receptor Type 5 Revenue by Country (2021-2026) & (US$ Million) Table 71. North America C-C Chemokine Receptor Type 5 Revenue by Country (2027-2032) & (US$ Million) Table 72. Europe C-C Chemokine Receptor Type 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Europe C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 74. Europe C-C Chemokine Receptor Type 5 Sales by Country (2027-2032) & (W Units) Table 75. Europe C-C Chemokine Receptor Type 5 Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe C-C Chemokine Receptor Type 5 Revenue by Country (2027-2032) & (US$ Million) Table 77. Asia Pacific C-C Chemokine Receptor Type 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Asia Pacific C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 79. Asia Pacific C-C Chemokine Receptor Type 5 Sales by Country (2027-2032) & (W Units) Table 80. Asia Pacific C-C Chemokine Receptor Type 5 Revenue by Country (2021-2026) & (US$ Million) Table 81. Asia Pacific C-C Chemokine Receptor Type 5 Revenue by Country (2027-2032) & (US$ Million) Table 82. South America C-C Chemokine Receptor Type 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. South America C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 84. South America C-C Chemokine Receptor Type 5 Sales by Country (2027-2032) & (W Units) Table 85. South America C-C Chemokine Receptor Type 5 Revenue by Country (2021-2026) & (US$ Million) Table 86. South America C-C Chemokine Receptor Type 5 Revenue by Country (2027-2032) & (US$ Million) Table 87. Middle East and Africa C-C Chemokine Receptor Type 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 89. Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country (2027-2032) & (W Units) Table 90. Middle East and Africa C-C Chemokine Receptor Type 5 Revenue by Country (2021-2026) & (US$ Million) Table 91. Middle East and Africa C-C Chemokine Receptor Type 5 Revenue by Country (2027-2032) & (US$ Million) Table 92. Global C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (W Units) Table 93. Global C-C Chemokine Receptor Type 5 Sales by Type (2027-2032) & (W Units) Table 94. Global C-C Chemokine Receptor Type 5 Sales Market Share by Type (2021-2026) Table 95. Global C-C Chemokine Receptor Type 5 Sales Market Share by Type (2027-2032) Table 96. Global C-C Chemokine Receptor Type 5 Revenue by Type (2021-2026) & (US$ Million) Table 97. Global C-C Chemokine Receptor Type 5 Revenue by Type (2027-2032) & (US$ Million) Table 98. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Type (2021-2026) Table 99. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Type (2027-2032) Table 100. Global C-C Chemokine Receptor Type 5 Price by Type (2021-2026) & (US$/Unit) Table 101. Global C-C Chemokine Receptor Type 5 Price by Type (2027-2032) & (US$/Unit) Table 102. Global C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (W Units) Table 103. Global C-C Chemokine Receptor Type 5 Sales by Application (2027-2032) & (W Units) Table 104. Global C-C Chemokine Receptor Type 5 Sales Market Share by Application (2021-2026) Table 105. Global C-C Chemokine Receptor Type 5 Sales Market Share by Application (2027-2032) Table 106. Global C-C Chemokine Receptor Type 5 Revenue by Application (2021-2026) & (US$ Million) Table 107. Global C-C Chemokine Receptor Type 5 Revenue by Application (2027-2032) & (US$ Million) Table 108. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Application (2021-2026) Table 109. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Application (2027-2032) Table 110. Global C-C Chemokine Receptor Type 5 Price by Application (2021-2026) & (US$/Unit) Table 111. Global C-C Chemokine Receptor Type 5 Price by Application (2027-2032) & (US$/Unit) Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. C-C Chemokine Receptor Type 5 Distributors List Table 115. C-C Chemokine Receptor Type 5 Customers List Table 116. C-C Chemokine Receptor Type 5 Industry Trends Table 117. C-C Chemokine Receptor Type 5 Industry Drivers Table 118. C-C Chemokine Receptor Type 5 Industry Restraints Table 119. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. C-C Chemokine Receptor Type 5 Product Image Figure 5. Global C-C Chemokine Receptor Type 5 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global C-C Chemokine Receptor Type 5 Market Size (2021-2032) & (US$ Million) Figure 7. Global C-C Chemokine Receptor Type 5 Sales (2021-2032) & (W Units) Figure 8. Global C-C Chemokine Receptor Type 5 Average Price (US$/Unit) & (2021-2032) Figure 9. DS-001 Product Image Figure 10. CCL-14 Product Image Figure 11. BMS-813160 Product Image Figure 12. AG-1105 Product Image Figure 13. Others Product Image Figure 14. Infectious Disease Product Image Figure 15. Immunology Product Image Figure 16. Gastrointestinal Product Image Figure 17. Oncology Product Image Figure 18. Others Product Image Figure 19. Global C-C Chemokine Receptor Type 5 Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of C-C Chemokine Receptor Type 5, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 C-C Chemokine Receptor Type 5 Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global C-C Chemokine Receptor Type 5 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global C-C Chemokine Receptor Type 5 Sales by Region in 2025 Figure 25. Global C-C Chemokine Receptor Type 5 Revenue by Region in 2025 Figure 26. North America C-C Chemokine Receptor Type 5 Market Size by Country in 2025 Figure 27. North America C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2032) Figure 28. North America C-C Chemokine Receptor Type 5 Revenue Market Share by Country (2021-2032) Figure 29. United States C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe C-C Chemokine Receptor Type 5 Market Size by Country in 2025 Figure 33. Europe C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2032) Figure 34. Europe C-C Chemokine Receptor Type 5 Revenue Market Share by Country (2021-2032) Figure 35. Germany C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific C-C Chemokine Receptor Type 5 Market Size by Country in 2025 Figure 46. Asia Pacific C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific C-C Chemokine Receptor Type 5 Revenue Market Share by Country (2021-2032) Figure 48. China C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America C-C Chemokine Receptor Type 5 Market Size by Country in 2025 Figure 57. South America C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2032) Figure 58. South America C-C Chemokine Receptor Type 5 Revenue Market Share by Country (2021-2032) Figure 59. Brazil C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Colombia C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Middle East and Africa C-C Chemokine Receptor Type 5 Market Size by Country in 2025 Figure 64. Middle East and Africa C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2032) Figure 65. Middle East and Africa C-C Chemokine Receptor Type 5 Revenue Market Share by Country (2021-2032) Figure 66. Egypt C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. South Africa C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Israel C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Türkiye C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. GCC Countries C-C Chemokine Receptor Type 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Global C-C Chemokine Receptor Type 5 Sales Market Share by Type (2021-2032) Figure 72. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Type (2021-2032) Figure 73. Global C-C Chemokine Receptor Type 5 Price (US$/Unit) by Type (2021-2032) Figure 74. Global C-C Chemokine Receptor Type 5 Sales Market Share by Application (2021-2032) Figure 75. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Application (2021-2032) Figure 76. Global C-C Chemokine Receptor Type 5 Price (US$/Unit) by Application (2021-2032) Figure 77. C-C Chemokine Receptor Type 5 Value Chain Figure 78. C-C Chemokine Receptor Type 5 Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. C-C Chemokine Receptor Type 5 Industry Opportunities and Challenges

Scope & coverage.

Types
  • DS-001
  • CCL-14
  • BMS-813160
  • AG-1105
  • Others
Applications
  • Infectious Disease
  • Immunology
  • Gastrointestinal
  • Oncology
  • Others
Companies covered
  • Allergan Plc
  • American Gene Technologies International Inc
  • Bristol-Myers Squibb Company
  • ChemoCentryx Inc
  • Cytodyn Inc
  • Pharis Biotec GmbH
  • GlaxoSmithKline Plc
  • TaiwanJ Pharmaceuticals Co Ltd

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global C-C Chemokine Receptor Type 5 Market Size (2021-2032)
  4. 2.2.2 Global C-C Chemokine Receptor Type 5 Sales (2021-2032)
  5. 2.2.3 Global C-C Chemokine Receptor Type 5 Market Average Price (2021-2032)
  6. 2.3 C-C Chemokine Receptor Type 5 by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 DS-001
  9. 2.3.3 CCL-14
  10. 2.3.4 BMS-813160
  11. 2.3.5 AG-1105
  12. 2.3.6 Others
  13. 2.4 C-C Chemokine Receptor Type 5 by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Infectious Disease
  16. 2.4.3 Immunology
  17. 2.4.4 Gastrointestinal
  18. 2.4.5 Oncology
  19. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global C-C Chemokine Receptor Type 5 Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global C-C Chemokine Receptor Type 5 Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global C-C Chemokine Receptor Type 5 Revenue of Manufacturers (2021-2026)
  4. 3.4 Global C-C Chemokine Receptor Type 5 Average Price by Manufacturers (2021-2026)
  5. 3.5 Global C-C Chemokine Receptor Type 5 Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of C-C Chemokine Receptor Type 5, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of C-C Chemokine Receptor Type 5, Product Type & Application
  8. 3.8 Global Manufacturers of C-C Chemokine Receptor Type 5, Established Date
  9. 3.9 Global C-C Chemokine Receptor Type 5 Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Allergan Plc
  2. 4.1.1 Allergan Plc Company Information
  3. 4.1.2 Allergan Plc Business Overview
  4. 4.1.3 Allergan Plc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Allergan Plc C-C Chemokine Receptor Type 5 Product Portfolio
  6. 4.1.5 Allergan Plc Recent Developments
  7. 4.2 American Gene Technologies International Inc
  8. 4.2.1 American Gene Technologies International Inc Company Information
  9. 4.2.2 American Gene Technologies International Inc Business Overview
  10. 4.2.3 American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Product Portfolio
  12. 4.2.5 American Gene Technologies International Inc Recent Developments
  13. 4.3 Bristol-Myers Squibb Company
  14. 4.3.1 Bristol-Myers Squibb Company Company Information
  15. 4.3.2 Bristol-Myers Squibb Company Business Overview
  16. 4.3.3 Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Product Portfolio
  18. 4.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 4.4 ChemoCentryx Inc
  20. 4.4.1 ChemoCentryx Inc Company Information
  21. 4.4.2 ChemoCentryx Inc Business Overview
  22. 4.4.3 ChemoCentryx Inc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 ChemoCentryx Inc C-C Chemokine Receptor Type 5 Product Portfolio
  24. 4.4.5 ChemoCentryx Inc Recent Developments
  25. 4.5 Cytodyn Inc
  26. 4.5.1 Cytodyn Inc Company Information
  27. 4.5.2 Cytodyn Inc Business Overview
  28. 4.5.3 Cytodyn Inc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Cytodyn Inc C-C Chemokine Receptor Type 5 Product Portfolio
  30. 4.5.5 Cytodyn Inc Recent Developments
  31. 4.6 Pharis Biotec GmbH
  32. 4.6.1 Pharis Biotec GmbH Company Information
  33. 4.6.2 Pharis Biotec GmbH Business Overview
  34. 4.6.3 Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Product Portfolio
  36. 4.6.5 Pharis Biotec GmbH Recent Developments
  37. 4.7 GlaxoSmithKline Plc
  38. 4.7.1 GlaxoSmithKline Plc Company Information
  39. 4.7.2 GlaxoSmithKline Plc Business Overview
  40. 4.7.3 GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Product Portfolio
  42. 4.7.5 GlaxoSmithKline Plc Recent Developments
  43. 4.8 TaiwanJ Pharmaceuticals Co Ltd
  44. 4.8.1 TaiwanJ Pharmaceuticals Co Ltd Company Information
  45. 4.8.2 TaiwanJ Pharmaceuticals Co Ltd Business Overview
  46. 4.8.3 TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Product Portfolio
  48. 4.8.5 TaiwanJ Pharmaceuticals Co Ltd Recent Developments
5 Global C-C Chemokine Receptor Type 5 Market Scenario by Region
  1. 5.1 Global C-C Chemokine Receptor Type 5 Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global C-C Chemokine Receptor Type 5 Sales by Region: 2021-2032
  3. 5.2.1 Global C-C Chemokine Receptor Type 5 Sales by Region: 2021-2026
  4. 5.2.2 Global C-C Chemokine Receptor Type 5 Sales by Region: 2027-2032
  5. 5.3 Global C-C Chemokine Receptor Type 5 Revenue by Region: 2021-2032
  6. 5.3.1 Global C-C Chemokine Receptor Type 5 Revenue by Region: 2021-2026
  7. 5.3.2 Global C-C Chemokine Receptor Type 5 Revenue by Region: 2027-2032
  8. 5.4 North America C-C Chemokine Receptor Type 5 Market Facts & Figures by Country
  9. 5.4.1 North America C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
  11. 5.4.3 North America C-C Chemokine Receptor Type 5 Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe C-C Chemokine Receptor Type 5 Market Facts & Figures by Country
  16. 5.5.1 Europe C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
  18. 5.5.3 Europe C-C Chemokine Receptor Type 5 Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific C-C Chemokine Receptor Type 5 Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific C-C Chemokine Receptor Type 5 Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America C-C Chemokine Receptor Type 5 Market Facts & Figures by Country
  41. 5.7.1 South America C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
  43. 5.7.3 South America C-C Chemokine Receptor Type 5 Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa C-C Chemokine Receptor Type 5 Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa C-C Chemokine Receptor Type 5 Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa C-C Chemokine Receptor Type 5 Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global C-C Chemokine Receptor Type 5 Sales by Type (2021-2032)
  2. 6.1.1 Global C-C Chemokine Receptor Type 5 Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global C-C Chemokine Receptor Type 5 Sales Market Share by Type (2021-2032)
  4. 6.2 Global C-C Chemokine Receptor Type 5 Revenue by Type (2021-2032)
  5. 6.2.1 Global C-C Chemokine Receptor Type 5 Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global C-C Chemokine Receptor Type 5 Revenue Market Share by Type (2021-2032)
  7. 6.3 Global C-C Chemokine Receptor Type 5 Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global C-C Chemokine Receptor Type 5 Sales by Application (2021-2032)
  2. 7.1.1 Global C-C Chemokine Receptor Type 5 Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global C-C Chemokine Receptor Type 5 Sales Market Share by Application (2021-2032)
  4. 7.2 Global C-C Chemokine Receptor Type 5 Revenue by Application (2021-2032)
  5. 7.2.1 Global C-C Chemokine Receptor Type 5 Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global C-C Chemokine Receptor Type 5 Revenue Market Share by Application (2021-2032)
  7. 7.3 Global C-C Chemokine Receptor Type 5 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 C-C Chemokine Receptor Type 5 Value Chain Analysis
  2. 8.1.1 C-C Chemokine Receptor Type 5 Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 C-C Chemokine Receptor Type 5 Production Mode & Process
  5. 8.2 C-C Chemokine Receptor Type 5 Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 C-C Chemokine Receptor Type 5 Distributors
  8. 8.2.3 C-C Chemokine Receptor Type 5 Customers
9 Global C-C Chemokine Receptor Type 5 Analyzing Market Dynamics
  1. 9.1 C-C Chemokine Receptor Type 5 Industry Trends
  2. 9.2 C-C Chemokine Receptor Type 5 Industry Drivers
  3. 9.3 C-C Chemokine Receptor Type 5 Industry Opportunities and Challenges
  4. 9.4 C-C Chemokine Receptor Type 5 Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst